-

Medical Devices

  • Share Share this page

FDA Workshop: Implementation of Post Approval Studies for Medical Devices, June 4-5, 2009


Date, Time and Location

The meeting will be held on June 4, 2009 from 9:00 a.m. to 5 p.m. and June 5, 2009 from 9:00 a.m. to 12;00 noon at the following location:

Food and Drug Administration
Building 2, Room 2031
10903 New Hampshire Ave.
Silver Spring , MD 20993

* Please allow sufficient time for security screening.

Back to Top Arrow


Agenda

Day 1 (June 4)

8:00 am Breakfast and Registration
9:00 am Welcome
9:00 am Daniel Schultz, MD, CDRH
9:05 am Susan Gardner, PhD, CDRH
9:10 am Donna-Bea Tilman, PhD, CDRH
Challenges in Patient Recruitment and Retention: (15 min each and one 10 min Q/A period)
9:15 am Danica Marinac-Dabic, MD, Ph.D, CDRH, Workshop goals
9:30 am Todd Fonseca, Medtronic, Industry perspective on patient recruitment
9:45 am Danica Marinac-Dabic, MD, PhD, CDRH /OSB, Post-approval studies for medical devices: Challenges and opportunities
10:00 am Christine K. Pierre, RN, RxTrials, Inc., CRO perspective on patient recruitment
10:15 am Mark Boutin, JD, National Health Council, Patient perspective on clinical trialsparticipation
10:30 am Q & A period
10:40 am Coffee Break
10:55 am David Rutledge, PharmD , Abbott Vascular, Industry perspective on patient retention
11:10 am Mark Bray, PhD, Global Project Manager, CRO perspective on patient retention
11:25 am CDRH/ODE, Challenges in patient recruitment and retention: Bridging the premarket and postmarket
11:40 am Paul Gobel, Paul W. Goebel Consulting Inc, IRB considerations in implementing post-approval studies
11:55 am Q & A period
12:05 pm Lunch
Further Considerations in Implementing Post-Approval Studies : (15 min each and one 10 min Q/A period)
1:00 pm Ken Getz, Center for Information & Study on Clinical Research Participation (CISCRP), Where are we now, where do we go from here?
1:15 pm Steven Pashko, PhD, Global Late Phase Studies, Pharmacovigilance and Safety Omnicare Clinical Research, Recruitment of clinical sites for post-approval studies
1:30 pm Gerry Prudhomme, JD, Hogan and Hartson, LLP, Legal consideration of post-approval studies
1:45 pm Solomon Iyasu, MD, PhD, CDER/ OSE, Drugs and Devices: Common considerations in implementing post-approval studies
2:00 pm Q & A period
2:10 pm Break
2:20 pm Break-out-Sessions: Recruitment and Retention of Participants (Attendees will be broken into two groups)
Session I Leaders: Ellen Pinnow, MS, CDRH/OSB and Stan Harris, Wright Medical Technology
Session II Leaders: Daniel Canos MPH, CDRH/OSB and Heidi Hinrichs, St. Jude Medical
4:45 pm Summary of Day 1, Danica Marinac-Dabic, MD, Ph.D, CDRH/OSB

Day 2 (June 5)

8:00 am Breakfast/Discussions
9:00 am

Summary of Break-out Session and Discussions: What have we learned: Identifying the critical issues

Session I Leaders: Ellen Pinnow, MS, CDRH/OSB and Stan Harris, Wright Medical Technology

Session II Leaders: Daniel Canos MPH, CDRH/OSB and Heidi Hinrichs, St. Jude Medical

10:15 am Break
10:30 am Panel Discussion: Where do we go from here: Identifying priorities and next steps
Panelists include:
Joel Batts, Wright Medical Technology
Jodi Akin, MSN, Edwards Lifesciences
Thomas Gross, MD, MPH, CDRH/OSB
Malvina Eydelman, MD, CDRH/ODE
Michael Domanski, MD, NIH/NHLBI
CDRH/ODE Representative
11:50 am Summary Wrap-up, Danica Marinac-Dabic, MD, Ph.D, CDRH/OSB
12:00 noon End of Workshop

Back to Top Arrow


Registration

Registration will be handled by Social and Scientific Systems. To register please email your name, title, organization affiliation, address, and email contact information to SZafonte@s-3.com.

Registration will be on a first-come, first served basis. Non-US citizens are subject to additional security screening, and should register as early as possible.

Back to Top Arrow


Contacts

The workshop organizer may be contacted at:

Ellen Pinnow
Epidemiologist
Division of Epidemiology
Office of Surveillance and Biometrics
Center for Devices and Radiological Health,
Food and Drug Administration
1350 Piccard Drive
Rockville, MD 20850
Phone: (240) 276-2373
e-mail: ellen.pinnow@fda.hhs.gov

Back to Top Arrow

    
-
-
-
-
-